Late Breaking Abstracts

Thursday, May 25, 2017: 6:15 AM-8:15 AM
B2 (New Orleans Convention Center)
The Experience of Care Partners of Patients with MS: Outcomes from the Global vsMS™ Survey
Ann D. Bass, MD, Neurology Center of San Antonio; Bart Van Wijmeersch, MD, PhD, Rehabilitation & MS-Centre Overpelt, BIOMED, Hasselt University; Lori Mayer, DNP, MSN, RN, MSCN, Central Texas Neurology Consultants; Matt Mandel, MD, Sanofi; Kersten Sharrock, MS, Sanofi; Colin P Mitchell, PhD, Sanofi; Barry A Singer, MD, MS Center for Innovations in Care, Missouri Baptist Medical Center

Interesting Case Study: High Dose Vitamin D Protocol in Treating Aggressive RMS
Denise R Bruen, ANP-BC, MSCN, University of Virginia MS Clinic

Evaluation of Early Patient Engagement with a Mobile App and Digital Data Platform for Monitoring MS Disease Stability
Ryan Metzger, PhD, Rocky Mountain MS Research Group; Angel Christensen, BS, Rocky Mountain MS Research Group; Kara Menning, FNP-C, Rocky Mountain MS Research Group

Real-World Effectiveness of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Interim Results from the Effect Study
Stanley Cohan, MD, PhD, Providence Multiple Sclerosis Center; Andrew Chan, MD, Bern University Hospital, University of Bern; Jonathan Calkwood, MD, Schapiro Center for Multiple Sclerosis, Minneapolis Clinic of Neurology; Ellen S Lathi, MD, MS Center at St. Elizabeth's; Anneke Van der Walt, PhD, Royal Melbourne Hospital; Macaulay Okwuokenye, DrPH, BPharm, Biogen; Catherine Taylor, PharmD, Biogen

Longitudinal Changes in JCV Titers in Multiple Sclerosis (MS) Patients Treated with Rituximab, Fingolimod, and Dimethyl Fumarate
Sharon M Friedman-Urevich, DNP, NYUWinthrop Hospital; Malcolm Gottesman, MD, NYU Winthrop Hospital; Stephen Farley, PharmD, NYUWinthrop Hospital

ADS-5102 (amantadine) Extended Release Capsules in Multiple Sclerosis Patients with Walking Impairment: A Phase 2 Proof of Concept Study
Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute; Jeffrey A Cohen, MD, Cleveland Clinic Foundation; Mark Gudesblatt, MD, South Shore Neurologic Associates; Ben W Thrower, MD, Shepherd Center; Theodore R Brown, MD, MPH, Evergreen Health; Cindy Souza-Prien, n/a, Adamas Pharmaceuticals, Inc; David Chernoff, MD, Adamas Pharmaceuticals, Inc; Rajiv Patni, MD, Adamas Pharmaceuticals, Inc

Pregnancy and Delivery While on Natalizumabi: A Case Study
Diego Marin, D.O., Hudson Neurosciences; Gregory D Anselmi, M.D., Hudson Neurosciences

Real-World Strategies for Managing Gastrointestinal Events and Increasing Adherence with Delayed-Release Dimethyl Fumarate: Interim Analysis of a Sub-Study of Effect
Jinny Min, PharmD, Biogen; Jacob A. Sloane, MD PhD, Beth Israel Deaconess Medical Center; Macaulay Okwuokenye, DrPH, BPharm, Biogen; Catherine Taylor, PharmD, Biogen; J. Theodore Phillips, MD, PhD, FAAN, Baylor Institute for Immunology Research

Therapeutic Horseback Riding for Individuals with Multiple Sclerosis
Tara S. Patterson, PhD, University of Texas Medical Branch; Theresa M. Smith, PhD, OTR, CLVT, University of Texas Medical Branch; Kira E. Beal, OTR, OTD, CLT, CPAM, San Jacinto Community College

See more of: Late-Breaking
<< Previous Session | Next Session >>